ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
about
Primary angioplasty versus intravenous thrombolysis for acute myocardial infarctionLost in Translation (LiT): IUPHAR Review 6Cardiology's 10 greatest discoveries of the 20th centuryAntiplatelet therapy in acute coronary syndromes: focus on ticagrelorRisk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trialsThe angiotensin-converting enzyme inhibitor and aspirin interaction in congestive heart failure: fear or reality?Article makes simple errors and could cause unnecessary deathsChronic aspirin is effective--if data are massaged sufficiently.The effect of low-dose daily aspirin intake on survival in the Finnish centenarians cohortCurrent developments in anti-platelet therapyAcute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitorsThe big idea: the coxib crisis iron, aspirin and heart disease risk revisitedNormalization of platelet reactivity in clopidogrel-treated subjectsThe thrombolytic effect of aspirin in animal modelUsing an electronic medical record to identify opportunities to improve compliance with cholesterol guidelinesCost effectiveness of ramipril treatment for cardiovascular risk reductionThe risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease.Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction.GPs' reasons for referral of patients with chest pain: a qualitative study.Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis.The evolving role of platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes.Thrombolysis in acute myocardial infarction: the safety and efficiency of treatment in the accident and emergency department.Drugs used in secondary prevention after myocardial infarction: case presentation.Global perspective on acute coronary syndrome: a burden on the young and poor.Antiplatelet medications and their indications in preventing and treating coronary thrombosis.Primary angioplasty should be first line treatment for acute myocardial infarction: AGAINSTIs the Combination of Aspirin and Clopidogrel always Better than Aspirin Alone? Or will it be too much of a good thing?Excess of mortality in patients with chest pain peaks in the first 3 days period after the incident and normalizes after 1 month.Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.The advanced practice nurse's role regarding women's delay in seeking treatment with myocardial infarction.Pragmatic vs explanatory trials: the pragmascope tool to help measure differences in protocols of mental health randomized controlled trials.Myocardial infarction in an urban population: worse long term prognosis for patients from less affluent residential areasThe predicted impact of heart disease prevention and treatment initiatives on mortality in Lithuania, a middle-income countryA prospective study of long term prognosis in young myocardial infarction survivors: the prognostic value of angiography and exercise testingTrends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000'Add women & stir'--the biomedical approach to cardiac research!Korean National Health Insurance value incentive program: achievements and future directionsBleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.Regional differences in treatment frequency and case-fatality rates in korean patients with acute myocardial infarction using the Korea national health insurance claims database: findings of a large retrospective cohort study.
P2860
Q24248081-21B5046B-43ED-4A2C-91A5-0691B545F73DQ24289150-074E7047-33D2-403A-B859-B72E2E89A3C7Q24533369-A6F746A5-E87E-4387-88FF-955CC1C47D8CQ24605508-0A7963FB-94FD-4785-8182-AF56DEA2C0F3Q28166614-C1BCE425-3CF4-4742-88C9-F2F58220CB43Q28181924-9C3F5B20-D33E-48E1-ACBD-3EE393A49608Q28192179-1BC1B01D-309A-4BF8-BE89-551282AFA202Q28192280-EA452B4E-4541-4161-B458-602C1C8BF4DCQ28192522-968CCE0A-EAAE-47FC-B364-B3D84315ABCBQ28200685-628526EE-D8DD-429E-9161-C937A4869964Q28210545-66FED863-A263-4EDB-8F5F-2A943B096D58Q28217914-86A30590-B529-4EE4-8FE1-62E2D1A5686EQ28217935-6EAE5375-77D8-4E35-887F-4CCDE20EC56CQ28221834-E33F201C-65E5-42A8-A0D5-1F72BBFD644EQ28353024-FB82A8DC-01D9-4214-89DF-00DEC4494FFCQ28362658-0723178A-19CD-4617-A3DD-63B32A447026Q30234909-6D257C09-A18D-492F-BAFC-21062A3851BBQ31053398-196CA988-9C18-4555-B822-CBCA29DE1E3DQ33438981-39CBED53-5191-44CF-9204-E62725366E05Q33489028-760E7E6E-0207-450F-928A-8061B4832272Q33540026-0B36CCA1-9DFF-4805-99FD-6CF48B714233Q33689211-79318338-48F5-439A-B7A9-3FE5FD9420B1Q33743487-36C2C7FE-8F1E-419B-8527-B35F14CB5C51Q34078583-8F5AE7C2-E2E8-429F-95C9-309657310580Q34088547-6D68A3AB-A359-4628-A443-ACFE7534D9E4Q34111901-6439A5CE-B606-49DC-B1EA-1E2975AFCAAFQ34197354-E3A5F079-90CE-4511-9995-D85B30DD07B5Q34220492-7316AC33-DFF1-4E6F-8E64-E76DBB9B34E8Q34306450-BEDD7C96-E256-436A-BF6B-D6CCB91EB35EQ34793416-2838772B-9653-4EF7-98DB-D2802137DEA8Q34994208-914D875B-2172-46A1-9261-9F9BE4FC6A09Q35237334-0AE78AC5-987C-44D4-A1BC-DB4E5893F84DQ35406502-C10DA012-F07B-4F1B-839C-A7736C348726Q35565814-FED14E3E-E9A0-4F17-863C-F58C90605D78Q35581443-54B09C25-B1F0-4BF9-8951-E36529D27E56Q35771589-B8E2650A-6E92-4B80-AB5A-578B03F5BA1EQ35826826-9008769C-577E-42F2-B532-E80381AA68C3Q36031243-B4C47B81-3C38-4211-9448-3630713ECAD7Q36094923-509EE38B-AD99-4707-9EF2-6121EC611514Q36154124-5C0D59EB-61B5-494B-A499-11E3502AA21C
P2860
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
ISIS-2: 10 year survival among ...... Survival) Collaborative Group
@ast
ISIS-2: 10 year survival among ...... Survival) Collaborative Group
@en
type
label
ISIS-2: 10 year survival among ...... Survival) Collaborative Group
@ast
ISIS-2: 10 year survival among ...... Survival) Collaborative Group
@en
prefLabel
ISIS-2: 10 year survival among ...... Survival) Collaborative Group
@ast
ISIS-2: 10 year survival among ...... Survival) Collaborative Group
@en
P2093
P2860
P921
P1433
P1476
ISIS-2: 10 year survival among ...... Survival) Collaborative Group
@en
P2093
P2860
P304
P356
10.1136/BMJ.316.7141.1337
P407
P577
1998-05-01T00:00:00Z